A carregar...
Minireview: Challenges and Opportunities in Development of PPAR Agonists
The clinical impact of the fibrate and thiazolidinedione drugs on dyslipidemia and diabetes is driven mainly through activation of two transcription factors, peroxisome proliferator-activated receptors (PPAR)-α and PPAR-γ. However, substantial differences exist in the therapeutic and side-effect pro...
Na minha lista:
| Publicado no: | Mol Endocrinol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414793/ https://ncbi.nlm.nih.gov/pubmed/25148456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2013-1427 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|